Found: 6
Select item for more details and to access through your institution.
Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) – results from a nationwide cohort in Germany (GRAID).
- Published in:
- Lupus, 2013, v. 22, n. 11, p. 1142, doi. 10.1177/0961203313503912
- By:
- Publication type:
- Article
Epoetin Beta, Administered with the Multidose Formulation Reco-Pen, Is Effective, Safe and Convenient for Patients with Renal Anaemia.
- Published in:
- Kidney & Blood Pressure Research, 2004, v. 27, n. 5/6, p. 319
- By:
- Publication type:
- Article
Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID).
- Published in:
- Journal of NeuroImmune Pharmacology, 2016, v. 11, n. 1, p. 1, doi. 10.1007/s11481-015-9646-5
- By:
- Publication type:
- Article
314 Low internight variability of sleep disordered breathing in stable heart failure
- Published in:
- 2007
- By:
- Publication type:
- Abstract
314 Low internight variability of sleep disordered breathing in stable heart failure
- Published in:
- 2007
- By:
- Publication type:
- Abstract
A prospective observational safety study of patients with BRAF<sup>V</sup><sup>600</sup>‐mutated unresectable or metastatic melanoma treated with vemurafenib (Zelboraf Safety Study).
- Published in:
- British Journal of Dermatology, 2019, v. 180, n. 5, p. 1254, doi. 10.1111/bjd.17465
- By:
- Publication type:
- Article